Episodes

  • What Cardiologists Should Know About Congenital Heart Disease, Cardiac Arrest and Death in Athletes, Arrhythmia After Stroke

    What Cardiologists Should Know About Congenital Heart Disease, Cardiac Arrest and Death in Athletes, Arrhythmia After Stroke
    Dec 18 2024

    In this week’s View, Dr. Eagle looks at what adult cardiologists should know about congenital heart disease patients. He then discusses sudden cardiac arrest and death in competitive and recreational athletes. Finally, Dr. Eagle explores practical approaches for arrhythmia monitoring after stroke.

    Subscribe to Eagle’s Eye View

    Show More Show Less
    11 mins
  • Management of Myocarditis; Sex Differences in PCI vs. CABG; RVOT Dysfunction in Repaired TOF

    Management of Myocarditis; Sex Differences in PCI vs. CABG; RVOT Dysfunction in Repaired TOF
    Dec 11 2024

    In this week’s View, Dr. Eagle looks at the 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. He then discusses sex differences in patients undergoing FFR-guided PCI or CABG in the FAME 3 Trial. Finally, Dr. Eagle explores long-term management of right ventricular outflow tract (RVOT) dysfunction in repaired tetralogy of Fallot (TOF).

    Subscribe to Eagle’s Eye View

    Show More Show Less
    10 mins
  • Compression Tights in Patients With POTS, Platelet Function and Genetic Testing in PCI, Aspirin in Stent Patients Undergoing Noncardiac Surgery

    Compression Tights in Patients With POTS, Platelet Function and Genetic Testing in PCI, Aspirin in Stent Patients Undergoing Noncardiac Surgery
    Dec 4 2024
    In this week’s View, Dr. Eagle looks at the use of waist-high compression tights in patients with postural orthostatic tachycardia syndrome (POTS). He then discusses a consensus statement on platelet function and genetic testing in percutaneous coronary intervention (PCI). Finally, Dr. Eagle explores aspirin monotherapy versus no antiplatelet therapy in stable patients with coronary stents undergoing low-to-intermediate-risk noncardiac surgery. Subscribe to Eagle’s Eye View
    Show More Show Less
    9 mins
  • Prevalence of U.S. Overweight and Obesity, Consensus on CPR, Bleeding Risk Using NSAIDs With Anticoagulants

    Prevalence of U.S. Overweight and Obesity, Consensus on CPR, Bleeding Risk Using NSAIDs With Anticoagulants
    Nov 27 2024

    In this week’s View, Dr. Eagle looks at the prevalence of overweight and obesity among children, adolescents, and adults in the U.S., with forecasts up to 2050. He then discusses consensus recommendations on cardiopulmonary resuscitation (CPR). Finally, Dr. Eagle explores bleeding risk using nonsteroidal anti-inflammatory drugs (NSAIDs) with anticoagulants after venous thromboembolism.

    Subscribe to Eagle’s Eye View

    Show More Show Less
    8 mins
  • Top Six Trials From AHA 2024: BROAD, SUMMIT, OPTION, CLEAR SYNERGY (Spironolactone and Colchicine), My Heart Your Heart

    Top Six Trials From AHA 2024: BROAD, SUMMIT, OPTION, CLEAR SYNERGY (Spironolactone and Colchicine), My Heart Your Heart
    Nov 21 2024

    In this special edition of Eagle’s Eye View, Dr. Eagle looks at the most important trials presented at the recent AHA scientific sessions: 1) BROAD, exploring more intensive blood pressure control; 2) SUMMIT, evaluating tirzepatide use in obesity-related HFpEF in people with diabetes; 3) OPTION, comparing left atrial appendage closure to oral anticoagulation therapy for stroke protection in post-ablation patients with atrial fibrillation; 4) CLEAR SYNERGY, dual trials on the use of spironolactone vs. placebo and colchicine vs. placebo in patients with myocardial infarction, and 5) Project My Heart Your Heart, developing a protocol of the use of refurbished pacemakers.

    Subscribe to Eagle’s Eye View

    Show More Show Less
    13 mins
  • Exercise Training in HCM; Management of Kawasaki Disease; Race, Social Determinants of Health, Polygenic Risk for CHD

    Exercise Training in HCM; Management of Kawasaki Disease; Race, Social Determinants of Health, Polygenic Risk for CHD
    Nov 20 2024

    In this week’s View, Dr. Eagle looks at exercise training in patients with hypertrophic cardiomyopathy (HCM). He then reviews the diagnosis and management of Kawasaki Disease. Finally, Dr. Eagle discusses the association of self-reported race, social determinants of health (SDoH), and polygenic risk for coronary heart disease (CHD).

    Subscribe to Eagle’s Eye View

    Show More Show Less
    9 mins
  • Transseptal Mitral Valve-in-Valve Procedure, Complete vs. Culprit-Only Revascularization in Older Patients, Hypertensive Pregnancy and MI Risk

    Transseptal Mitral Valve-in-Valve Procedure, Complete vs. Culprit-Only Revascularization in Older Patients, Hypertensive Pregnancy and MI Risk
    Nov 13 2024
    In this week’s View, Dr. Eagle looks at contemporary outcomes and trends for the transseptal mitral valve-in-valve procedure using balloon-expandable transcatheter valves. He then explores complete vs. culprit-only revascularization in older patients with myocardial infarction (MI) with or without ST-segment elevation. Finally, Dr. Eagle discusses hypertensive disorders of pregnancy and whether they increase the risk for MI. Subscribe to Eagle’s Eye View
    Show More Show Less
    8 mins
  • TAVR in Younger Patients; Atorvastatin vs. Rosuvastatin; Sedentary Behavior and Blood Pressure

    TAVR in Younger Patients; Atorvastatin vs. Rosuvastatin; Sedentary Behavior and Blood Pressure
    Nov 6 2024
    In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients. He then explores the comparative effectiveness and safety of atorvastatin versus rosuvastatin. Finally, Dr. Eagle discusses the results of the RESET-BP randomized trial that studied the effects of sedentary behavior’s reduction of blood pressure in desk workers. Subscribe to Eagle’s Eye View
    Show More Show Less
    7 mins